Abstract comparison of B7-33 and full-length relaxin engaging the same receptor.
Mindful Research

B7-33 vs Full-Length Relaxin in Research Models

By: Mindful Research Team1 min read

Key takeaways

  • B7-33 is a single-chain peptide; full-length relaxin is a two-chain hormone.
  • Both target RXFP1.
  • The single-chain design is simpler to synthesize and characterize.
  • It is a simplified tool for studying RXFP1 signaling in vitro.
  • For in vitro research use only.

Referenced in this article

B7-33 B7-33$80.00 Shop now

B7-33 differs from full-length relaxin in being a single-chain peptide rather than a two-chain hormone, which makes it a simpler tool for studying RXFP1 activation in vitro. This guide compares the two.

Structural difference

Full-length relaxin is a two-chain, disulfide-linked peptide; B7-33 is a single chain derived from relaxin’s B-chain.

Why it matters in research

A single-chain peptide is simpler to synthesize and characterize, which is useful when studying RXFP1 signaling without the complexity of the two-chain structure.

Comparison table

Property Full-length relaxin B7-33
Chains Two (A + B) One
Receptor RXFP1 RXFP1
Research use Native reference Simplified single-chain tool

Source B7-33 with a batch COA for reproducible comparisons.

Related research guides

Research-use note

All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.

Frequently asked questions

How is B7-33 different from relaxin?

B7-33 is a single-chain peptide derived from relaxin's B-chain; relaxin is a two-chain hormone. Both target RXFP1. View B7-33

Why use B7-33 instead of relaxin?

As a simpler single-chain tool for studying RXFP1 activation in vitro.

Research use only?

Yes, in vitro laboratory research use only.

More research materials